Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.23) by 91.3 percent. This is a 33.33 percent decrease over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $18.53 million which missed the analyst consensus estimate of $19.13 million by 3.14 percent. This is a 3.61 percent increase over sales of $17.88 million the same period last year.